NanoInk
 | This article needs additional citations for verification. (October 2010) |
 | |
| Company type | Private |
|---|---|
| Industry | Nanotechnology, Pharmaceuticals |
| Founded | 2002 |
| Headquarters | Skokie, Illinois, U.S. |
| Website | www |
NanoInk, Inc. was a nanotechnology company headquartered in Skokie, Illinois, with a MEMS fabrication facility in Campbell, California.
A spin-off of Northwestern University and founded by Northwestern professor Chad Mirkin, NanoInk specialized in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Dip Pen Nanolithography (DPN) was a patented and proprietary nanofabrication technology[clarification needed] marketed as an anti-counterfeiting aid for pharmaceutical products.
Other key applications included nanoscale additive repair and nanoscale rapid prototyping. Located in the Illinois Science + Technology Park, north of Chicago, NanoInk had nearly 400 patents and applications filed worldwide and had licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.
Within seven months of its formation, the firm released its first product, the DPN-System-1, which turned any atomic force microscope into a DPN machine.[1]
In February 2013, NanoInk announced it would be shutting down due to insufficient funding when its primary backer, Ann Lurie, decided to pull the plug after investing $150 million over a decade.[2]